Acidcare

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acidcare

Understanding Acidcare

Acidcare is a pharmacological treatment categorized as a proton pump inhibitor (PPI). It is primarily utilized to manage conditions associated with excessive gastric acid production. By targeting the physiological mechanisms within the stomach lining, it helps regulate the internal environment to facilitate the healing of acid-related tissue damage.

Primary Uses

This medication is commonly employed in the management of several gastrointestinal conditions:

  • Gastroesophageal Reflux Disease (GERD): A chronic condition where stomach acid frequently flows back into the esophagus, causing irritation and discomfort.
  • Gastric and Duodenal Ulcers: Open sores that develop on the inner lining of the stomach or the upper portion of the small intestine.
  • Zollinger-Ellison Syndrome: A rare condition characterized by the development of tumors in the pancreas or duodenum that secrete excess gastrin, leading to overproduction of stomach acid.
  • Erosive Esophagitis: Inflammation and tissue damage in the esophagus resulting from prolonged exposure to gastric acid.

Mechanism of Action

Acidcare functions by inhibiting the H^+/K^+-ATPase enzyme system, often referred to as the "proton pump," located in the parietal cells of the stomach wall. This enzyme system represents the final stage of acid secretion. By blocking these pumps, the medication effectively reduces the total volume of hydrochloric acid released into the digestive tract. This reduction in acidity allows the esophageal and gastric mucosa time to recover and prevents further irritation of sensitive tissues.

Regulatory References

  1. NIH: Omeprazole Review

What side effects are possible with Acidcare?

Possible Side Effects and Safety Information

The official safety profile of Acidcare (Omeprazole) is structured by governmental regulatory agencies to categorize potential adverse reactions based on their documented frequency and affected physiological systems. The majority of reported side effects are gastrointestinal, reflecting the medicine's focus on the digestive tract.


Official Adverse Reaction Categories

Classification Examples of Reactions
Common Headache, diarrhea, abdominal pain, constipation, flatulence, nausea, or vomiting.
Uncommon Insomnia, dizziness, somnolence, paresthesia, skin rash, pruritus, and general malaise.
Rare/Very Rare Severe hepatic failure, blood disorders (leucopenia, agranulocytosis), acute interstitial nephritis, and serious cutaneous reactions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

Specific Safety Considerations

Certain safety concerns are documented in relation to the duration of use. Long-term use and/or high doses are officially associated with an increased risk of bone fractures of the hip, wrist, or spine, as well as the potential for hypomagnesaemia and the development of benign fundic gland polyps. Safety information also addresses specific populations; clearance is reduced in individuals with hepatic impairment, though no general dose adjustment is specified for mild-to-moderate cases. The concomitant use of Omeprazole with certain antiretroviral drugs, such as nelfinavir, is explicitly contraindicated in the regulatory labeling.

Overdose and Emergency Response

Overdose and When to Seek Help

The information below summarizes the documented overdose profile and required actions, strictly according to government regulatory sources.

Feature Regulatory Documentation Statement
Documented Overdose Presentations Overdosage has been associated with transient symptoms including confusion, drowsiness, tachycardia (increased heart rate), nausea, vomiting, headache, dry mouth, flushing, and increased sweating.
Severity Classification Symptoms reported were transient with no serious clinical outcome reported in overdosage cases up to 900 mg.
Antidote Availability No specific antidote for the drug is known.

Emergency Actions and Required Medical Attention

Regulatory guidance explicitly states that an overdose requires contacting immediate emergency medical assistance or calling the Poison Help line. Urgent medical help must be sought if the individual has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened, as noted in official drug information.

Treatment management is officially defined as symptomatic and supportive. Due to the drug's extensive protein binding, regulatory documents indicate that the compound is not readily dialyzable (removable by blood filtration).

The official overdose profile is structured around the requirement to seek medical attention for any suspected ingestion above recommended levels, while clarifying that documented manifestations are transient and typically managed by supportive care.

Therapeutic Uses of Acidcare

Acidcare is an antacid that is applied in addressing symptoms related to physical discomfort and heightened physiological activity. It is relevant in contexts involving heightened systemic burden. Products in this therapeutic domain are commonly used to help with the relief of symptoms related to systemic imbalance, such as heartburn, sour stomach, and acid indigestion associated with excess stomach acid (gastric hyperacidity).

This supportive relief contributes to easing the overall symptom load, particularly during periods of heightened symptoms or acute episodes. Acidcare is generally applied in scenarios where additional management of discomfort is required, often used during phases when symptoms become more noticeable. The common indications it addresses include acid indigestion, sour stomach, heartburn, and non-ulcer dyspepsia.

“It provides supportive relief that may assist with maintaining functional stability when symptoms interfere with routine activities.”

It is applied in addressing the temporary physiological imbalance caused by acid, and the product contributes to improved comfort during symptomatic phases.

Quick Fact: Relief for Symptoms that interfere with daily functioning

Regulatory References

  1. Health Canada Antacid Labelling Standard

Eligibility and Restrictions for Use

Eligibility and Contraindications

Acidcare (Omeprazole) is defined by regulatory bodies as safe for use in adults and certain pediatric patients. Absolute restrictions, known as contraindications, apply to patients with a known hypersensitivity to Omeprazole, the substituted benzimidazole class, or any of the product's components. Use is also formally contraindicated if the patient is currently taking the specific antiretroviral drug nelfinavir or rilpivirine, as this may lead to treatment failure.

Population Group Eligibility Status (Regulatory Basis)
Children under 1 year of age Not established (Safety and effectiveness have not been demonstrated).
Pediatric patients ge 1 year Approved (Established for symptomatic GERD and erosive esophagitis).
Pregnancy Generally accepted (Based on available human data).
Hepatic Impairment Conditional use (Caution is advised; dose adjustment may be necessary).
Renal Impairment Permitted (Dose adjustment is typically not required).

Eligibility also requires that a potential gastric malignancy be excluded prior to therapy. Furthermore, long-term use in the elderly is officially associated with an increased risk of bone fracture, which places a constraint on extended eligibility.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Acidcare (Omeprazole) interacts with various medicines primarily through two pharmacokinetic mechanisms: its effect on gastric pH and its inhibition of the CYP2C19 enzyme in the liver. All interactions below are officially documented in regulatory sources.


Formal Regulatory Restrictions

Co-administration with the antivirals Nelfinavir and Rilpivirine is contraindicated due to the risk of a significant reduction in the antiviral drug’s plasma concentration, leading to potential loss of efficacy. The combination with the antiplatelet medicine Clopidogrel is also officially restricted because Omeprazole inhibits its metabolic activation.

Documented Exposure Changes

Omeprazole’s inhibition of CYP2C19 can increase the plasma concentrations of co-administered drugs like Diazepam, Phenytoin, and the anticoagulant Warfarin. Conversely, medicines that induce the CYP enzymes, such as Rifampin and the herbal product St John's Wort, can reduce Omeprazole’s systemic exposure.

The change in gastric pH alters drug absorption, leading to decreased systemic exposure for acid-dependent medicines like Ketoconazole and Itraconazole, while resulting in increased exposure for drugs like Digoxin. Additionally, co-administration with Methotrexate may increase and prolong its serum concentration.

Mechanism of Action

How Acidcare Works

Acidcare is a prodrug that is converted to its active sulfenamide form specifically within the highly acidic environment of the parietal cell's secretory canaliculus. The active form then targets and inhibits the H^+/ K^+- ATPase (proton pump), which is the final enzymatic step in the cascade responsible for gastric acid secretion.


The active sulfenamide metabolite covalently binds to specific cysteine residues on the H^+/ K^+- ATPase enzyme. This targeted binding process is irreversible, resulting in a prolonged and stable deactivation of the enzyme’s pumping function and H^+ ion exchange.


The resulting inhibition cascade significantly reduces the overall volume of H^+-rich fluid secreted into the gastric lumen. This action leads directly to a substantial decrease in the H^+ ion concentration within the stomach.

Dosage and Administration Information

How to Use Acidcare

Acidcare (Omeprazole) is administered via two approved routes: oral delivery, which is standard for most patients, and intravenous (IV) infusion, used when a patient cannot take the medicine by mouth. The drug is formulated as delayed-release capsules or tablets, and its use is highly dependent on maintaining the integrity of this specialized coating.


Official Dosing and Administration Patterns

Usage Principle Standard Regulatory Instruction
Timing and Frequency The oral dose is typically taken once daily in the morning, before a meal. Twice-daily administration is reserved for specific H. pylori regimens or high-dose hypersecretory conditions.
Oral Handling Capsules and tablets must be swallowed whole. They must not be chewed, crushed, or split, as this destroys the enteric coating and may compromise drug release.
Standard Dose Range The dose most commonly used for healing is 20 mg once daily, while more severe conditions may necessitate 40 mg once daily. Doses for pathological hypersecretory states are higher and individualized.
Course Duration Initial courses for healing ulcers and esophagitis typically last 4 to 8 weeks. Long-term use is approved for maintenance and for specific chronic conditions.

Special Procedural Requirements

Patients with known hepatic impairment may require a dose adjustment, with recommendations for maintenance therapy often starting at 10 mg daily. If a dose is missed, it should be taken as soon as remembered, unless it is close to the time for the next scheduled dose, in which case the missed dose is skipped. The IV formulation requires specific dilution with only 0.9% sodium chloride or 5% glucose solution and must be infused slowly over a 20 to 30-minute period.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Acidcare

The body of research for Omeprazole (the active ingredient in Acidcare) includes Randomized Controlled Trials (RCTs) and comprehensive systematic reviews. This evidence describes the design of studies that monitored changes in symptoms and clinical markers during the research periods.


Evidence for Use in Symptomatic Gastroesophageal Reflux Disease (GERD)

Research exploring the use of Omeprazole-based medicines for typical acid problems—such as heartburn and acid indigestion—has been applied in studies examining patient-reported outcomes. These studies monitored outcomes related to physical discomfort and functional imbalance over defined periods. Some studies reported patterns in which measurements of complete or adequate symptom resolution were observed in a specific subset of the studied populations. Long-term effects are not fully established based on these trials, which had follow-up durations that were limited to just a few weeks.


Evidence for Healing Damage (Erosive Esophagitis) and Preventing Recurrence

Omeprazole was evaluated in specific research contexts involving conditions linked to irritative states, such as Erosive Esophagitis (EE), which is marked by visible damage to the lining of the food pipe. These studies used the endoscopic healing rate as a clear, objective measure. Studies reported patterns related to the resolution of physical findings observed during the acute treatment period (four to eight weeks). Other trials explored maintenance to monitor the durability of the healed state. Data for long-term outcomes are not fully established for use extending past this one-year period.


Evidence for Healing Peptic Ulcers and Managing H. pylori

Omeprazole was studied for research contexts involving active Duodenal Ulcers (DU) and Gastric Ulcers (GU), where the resolution of ulcers was monitored. Additionally, research explored the use of Omeprazole in combination therapies to monitor the eradication rate of the H. pylori bacterium. Observed patterns suggest the outcome is highly dependent on the specific combination therapy used. Research highlights that the results apply only to the populations studied.

Key Studies & References Antacid Labeling Standard (Non-Prescription Drugs)

Frequently Asked Questions (FAQ)

Common questions about Acidcare (FAQ)

Q: How fast does Acidcare typically start working?

Official drug information indicates that Acidcare begins working within one hour of administration. However, because it targets the body's acid pumps, the maximal acid-reducing effect is typically observed after about four consecutive days of regular daily dosing.

Q: What is the typical duration of treatment with Acidcare?

The initial treatment course for healing conditions like ulcers and erosive esophagitis is typically defined to last four to eight weeks. Long-term use is officially approved and established for maintenance therapy and for certain chronic conditions.

Q: Is Acidcare meant to be taken every day, or just when needed?

For treating and healing conditions, the drug is typically taken once daily as part of a defined treatment course. Because of its mechanism of action, it is not intended for use as an immediate, as-needed relief medicine for symptoms.

Q: Does Acidcare need to be taken before or after a meal?

Official instructions state that the oral dose is typically taken once daily in the morning, before a meal. This timing is based on findings that promote optimal medicine activity.

Q: What should I do if I forget to take my Acidcare dose?

Official guidelines describe that the missed dose is taken as soon as it is remembered, or is skipped if it is near the time for the next dose. Taking two doses at once is not recommended in the product information.

Q: Can Acidcare be crushed or mixed with food?

The capsules and tablets are formulated to be swallowed whole and are not designed to be chewed, crushed, or split, as this damages the specialized coating. Specific powder formulations, however, are described as suitable for mixing with water or a small amount of applesauce for administration.

Q: What is the main difference between Acidcare and proton pump inhibitors (PPIs)?

Official definitions state that Acidcare is the brand name for the active ingredient Omeprazole. This active ingredient is the prototype compound for the entire Proton Pump Inhibitor (PPI) pharmacological class.

Q: Why do doctors prescribe Acidcare for uses other than just heartburn?

The medicine has been studied and officially approved for contexts beyond simple heartburn relief. These include the healing of Erosive Esophagitis (damage to the food pipe lining), the management of Peptic Ulcers, and its use in combination therapies for H. pylori eradication.

Q: Are there long-term studies on the use of Acidcare?

Research exploring maintenance therapy has been conducted and is described in official documents. However, official information also states that long-term effects are not fully established, and the data for use extending past one year is limited.

Q: Is it possible to develop a tolerance to Acidcare over time?

Studies have examined the consistency of the medicine's effects over time. Official research has specifically found no evidence of a diminishing effect or development of tolerance during a study period of six months with consistent daily use.

Q: Is there a known withdrawal effect if I stop taking Acidcare suddenly?

Regulatory research has examined the potential for a condition called rebound acid hypersecretion when the medicine is stopped abruptly after a period of prolonged use. This describes a temporary increase in acid production that can occur after discontinuation.

Q: What are the most commonly reported side effects of Acidcare?

According to the official safety profile, the most commonly reported side effects are generally gastrointestinal. These include headache, diarrhea, abdominal pain, constipation, flatulence, nausea, or vomiting.

Q: Can Acidcare cause stomach upset?

The medicine's safety profile lists several common gastrointestinal reactions. These include symptoms such as diarrhea, abdominal pain, constipation, nausea, and vomiting, which can be summarized as forms of stomach upset.

Q: Is it normal to feel a little dizzy after starting Acidcare?

The official safety profile lists dizziness as an uncommon reported side effect of the medicine. This means it has occurred in a small subset of patients in studies.

Q: Does Acidcare cause fatigue or tiredness in most people?

The official safety profile lists somnolence (drowsiness) and a general feeling of malaise (discomfort) as uncommon reactions. Tiredness or fatigue is not listed among the commonly reported side effects.

Q: Is Acidcare considered non-sedating?

While the medicine is not categorized as a sedating drug, the official safety profile lists somnolence (drowsiness) as an uncommon adverse reaction. This indicates that it has been reported in a small percentage of patients during studies.

Q: Is it possible for Acidcare to cause an allergic reaction?

Yes, the drug is formally contraindicated in patients with a known hypersensitivity to the medicine or its components. The rare and very rare adverse reactions category also includes serious cutaneous reactions, which are types of severe allergic responses.

Q: Can I take other acid-reducing medicines at the same time as Acidcare?

Regulatory guidance states that antacids may be taken with Acidcare if needed for symptomatic relief. To ensure the medicine is absorbed correctly, the product information suggests separating the administration by a few hours to avoid affecting absorption.

Q: Does Acidcare interact with alcohol?

Regulatory guidance states there is no direct chemical interaction between Acidcare and alcohol. However, it is noted that alcohol consumption may worsen the underlying acid-related symptoms that the medicine is intended to manage.

Q: Can Acidcare be taken by people who are also taking blood pressure medication?

Official drug labeling advises that Acidcare interacts with various medicines, primarily due to its effect on the CYP2C19 enzyme. Because of this, it is described in official information that a full list of all medications is necessary for a healthcare provider to review potential interactions.

Q: Why does the label warn about mixing Acidcare with St. John's Wort?

According to regulatory documents, the herbal product St. John’s Wort can cause the body to metabolize Acidcare more quickly by activating certain liver enzymes. This process can significantly reduce the amount of Acidcare available in the body, which may affect its expected action.

Q: Why does the packaging mention potential interaction with certain antifungals?

The profound decrease in gastric acid (an increase in pH) caused by Acidcare can alter how other medicines are absorbed. This leads to decreased systemic exposure for certain acid-dependent medicines, such as the antifungals ketoconazole and itraconazole.

Q: Why is the information on eligibility important?

The eligibility requirements and contraindications (restrictions) are detailed in official documents to protect patient safety. This information is based on findings intended to maintain the medicine's expected benefit and prevent risks of serious adverse reactions in specific individuals and populations.

Q: Can older adults use Acidcare safely?

Regulatory information indicates that use in older adults is permitted. However, caution is advised because long-term use in the elderly is officially associated with an increased risk of bone fractures of the hip, wrist, or spine.

Q: Is Acidcare safe for people with kidney problems?

According to regulatory documentation, Acidcare is permitted for people with kidney impairment. Official information states that a dose adjustment is typically not required for patients with renal impairment.

Q: Has Acidcare been studied in children?

Official eligibility information confirms that the safety and effectiveness are established for pediatric patients ge 1 year of age for treating symptomatic GERD and erosive esophagitis. It is not established for children under 1 year of age.

Q: Are there different safety classifications for Acidcare based on patient groups?

Yes, the official eligibility information includes different regulatory statuses based on patient groups. For instance, the status for children under 1 year of age is not established, while use in children ge 1 year of age is approved for certain conditions.

Q: Does using Acidcare change the way my body absorbs vitamins?

Official safety information notes that long-term use is associated with an increased risk of hypomagnesaemia (low magnesium levels). Furthermore, research also describes a potential for decreased absorption of Vitamin B12 after chronic use of the medicine.

Q: Can Acidcare affect the results of any common lab tests?

Regulatory documents note that the use of Acidcare may cause an increase in levels of a substance called Chromogranin A (CgA). This increase can sometimes lead to false positive results when diagnostic tests are performed for certain neuroendocrine tumors.

Q: Does Acidcare contain any common allergens like gluten or lactose?

Official documents state that contraindications apply to patients with a known hypersensitivity to the active ingredient or any of the product’s components. The full inactive ingredient list is available and is the resource for identifying the presence of specific allergens.

Q: Are there any food restrictions mentioned when taking Acidcare?

Regulatory documents confirm that there are no specific food restrictions mentioned when using Acidcare. The recommendation is only that the medicine is typically taken once daily in the morning, before a meal, to ensure optimal absorption.

How should Acidcare be stored and disposed of?

Storage and Disposal Requirements for Acidcare

Acidcare (Omeprazole) must be stored strictly according to regulatory labeling to maintain its specialized delayed-release formulation.


Storage Conditions

Acidcare should be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), and must not be frozen. The medicine requires protection from light and moisture to preserve the integrity of the coating. For safety, the product must be kept in its original container, tightly closed, and out of the sight and reach of children.


Disposal Instructions

Unused or expired Acidcare must be handled following official guidelines. Patients are instructed to dispose of the product in accordance with local regulations and utilize a drug take-back program if available. Disposal via household waste or wastewater is generally advised against, as stated in regulatory documents.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Acidcare found in:

A-Z Index: